The mechanism of RCC therapeutic resistance is not fully understood, though it is speculated that the ATP-binding cassette (ABC)/p-glycoprotein transporter system in RCC may play a role [2–4]. This evidence concerns the gene ABCB6 and renal cell carcinoma.